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ABSTRACT 
 
The cardiovascular benefits of regular exercise have been well described, including a 
significant reduction in cardiovascular morbidity and mortality for those meeting 
recommended guidelines. Yet the impact of physical activity on the incidence of 
atrial fibrillation (AF) has been less clear. This review seeks to define the optimal 
dose and duration for the prevention and treatment of AF. In doing so, we review 
the evidence that supports a decline in AF risk for those who achieve a weekly 
physical activity dose slightly above the current recommended guidelines. 
Furthermore, we identify the reduced AF incidence in those individuals who attain a 
cardiorespiratory fitness of 8-METs or more during maximal exercise testing. Finally, 
we review the evidence that shows an excess of AF amongst regular participants of 
endurance exercise.  
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INTRODUCTION 
The incidence of atrial fibrillation (AF), the most common clinical arrhythmia, 
continues to grow.(1) Moreover, AF morbidity remains on the rise, leading to 
significant healthcare demands and poorer patient outcomes.(2) Although multiple 
factors contribute to the rise in AF incidence, the growing prevalence of obesity and 
other cardiovascular risk factors plays a significant role. The population attributable 
risk of AF for lifestyle-based risk factors (obesity, hypertension, type II diabetes) is 
almost 50%.(3) Given that exercise exerts largely favorable effects for the reduction 
of cardiovascular risk, the potential benefits for the prevention or management of AF 
may be considerable. 
The health benefits of exercise at the higher end of the dose-spectrum, such 
as that common to endurance sports, are less certain. Whilst a reduction in mortality 
is maintained, there is little to suggest any additional benefit.(4,5) Although exercise 
favors cardiovascular health, there is concern regarding the potential for competitive 
endurance sports and exercise to contribute to, or directly cause, cardiac 
arrhythmias. Although ventricular arrhythmias or sudden cardiac death can occur 
more frequently in athletes with underlying predominately genetic disorders, 
observational studies have revealed a predisposition towards atrial arrhythmias 
amongst those with otherwise normal hearts.(6,7)  
This review will seek to provide evidence that: (i) low physical activity and 
poor cardiorespiratory fitness contributes to increased AF incidence; (ii) exercise 
may provide therapeutic benefit in patients with AF; and (iii) endurance exercise 
significantly increases the risk of developing AF.  
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Physical Activity to Reduce AF Incidence 
Total Dose of Physical Activity 
The global burden of AF is growing rapidly, requiring urgent public health 
interventions to stem this rise.(8) Coronary heart disease and heart failure incidence 
are inversely related to physical activity levels.(9,10) However, the protective 
benefits of physical activity for AF are less clear. 
Several studies report a reduction in AF incidence with greater levels of 
physical activity. In the Cardiovascular Health Study,(11) lower AF incidence with 
higher doses of weekly physical activity (expressed as the combined distance and 
pace walked) was observed. For those with the highest self-reported physical 
activity, there was a 46% reduction in AF risk. In large cohorts of Swedish men and 
women, daily walking or cycling lowered the risk of AF by 12% and 19%, 
respectively.(12,13) However, in the Women’s Health Study, physical activity did not 
reduce AF incidence in adjusted analyses.(14) In later studies, the largest benefit of 
physical activity appeared to be mediated principally through a dampening of the AF 
risk associated with other AF risk factors. In the Atherosclerosis Risk in Communities 
study(15) and the Women’s Health Initiative Study,(16) physical activity partially 
offset the elevated risk of AF with obesity. Although its magnitude may be debated, 
there appears to be an overall benefit of greater physical activity for the reduction of 
incident AF. 
 
Intensity of Physical Activity 
Most studies reporting the association between physical activity and AF have 
focused on measures of total exercise, without identifying the contribution of 
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exercise intensity. However, a small number of studies have reported AF risk 
according to the intensity of exercise.  
Mozaffarian et.al, reported the self-rated intensity of physical activity and its 
subsequent AF risk.(11) A significant reduction in AF risk could be observed with 
moderate, but not high-intensity exercise. However, this model did not adjust for the 
total activity. Furthermore, details on the self-rating of exercise intensity were not 
clear, making it difficult to ascertain the precise level of exertion. 
More recent studies have explored the interaction between moderate and 
more vigorous forms of physical activity on AF risk. Bapat et.al,(17) concluded that 
more intensive physical activity alone did not reduce AF risk. However, greater 
volumes of intentional exercise (sum of walking for exercise, sports, conditioning and 
dance) reduced AF risk only in participants who included some vigorous physical 
activity, such as conditioning activities. In contrast, recent Scandinavian data 
suggests that moderate physical activity, defined as walking or cycling >4 
hours/week, reduces incident AF risk but this benefit is diminished in those who 
participate in more vigorous activities, including recreational and competitive 
sports.(18) Future studies in which the exercise intensity is objectively defined will 
enable better guidance on the most effective intensity of activity for modifying AF 
risk. 
 
Defining the Optimal Dose 
Using available evidence, it is possible to construct an analysis of the dose-response 
between physical activity and incident AF (Figure-1). The visual inspection of this plot 
highlights a modest benefit of physical activity at a dose of approximately 1000-1500 
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Met-minutes/week. Given the current guidelines recommending 150-minutes of 
moderate intensity activity/week (450-900 Met-minutes),(19) this analysis suggests 
that a ~10% decline in the risk of incident AF can be achieved by participating in 
regular physical activity in excess of the recommended guidelines. As an example, 
~220-minutes/week of moderate to brisk walking (4.5-Mets) would achieve a weekly 
dose of 1000-MET-minutes. 
The existing data should be considered in the context of several important 
points. First, the majority of studies quantify physical activity by self-report on study 
entry, leaving the potential for reporting bias and time-varying changes. 
Developments in the field of wearable technologies may provide more objective 
reporting of physical activity. Second, the detection of AF by hospital admissions or 
medical records, lacks sensitivity for asymptomatic or subclinical AF, or cases 
requiring minimal management. For example, studies using annual ECGs and hospital 
records showed a cohort wide incidence of 23 events/1000-person-years.(11) In 
contrast, studies relying primarily on self-reported AF incidence,(14) demonstrated a 
cohort-wide incidence of <2 events/1000-person-years. This illustrates the pivotal 
role of study design and AF ascertainment method in observational studies relating 
to AF incidence. 
 
Beyond Activity: Cardiorespiratory Fitness and AF Risk 
Cardiorespiratory fitness (CRF) is a strong predictor of mortality in healthy 
participants and patients with existing cardiovascular disease.(20,21) Intriguingly, 
some studies propose that it is CRF, rather than physical activity per se, that reduces 
mortality.(22)  
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The first evaluation of the relationship between CRF and incident AF came 
from 1950 middle aged men in the Kuopio Ischemic Heart Disease Study who 
underwent exercise testing at baseline to determine peak oxygen consumption 
(VO2peak).(23) Incident AF was assessed by hospital discharge diagnoses, study ECGs 
and inpatient claims data over a 19.5-year follow-up. After full adjustment for known 
risk factors, there was a significant reduction (30%) in AF risk for participants in the 
third quartile of CRF (Mean CRF: 9.3-METs) but not those in the upper quartile 
(Mean CRF: 11.6-METs). 
In a larger sample from the Henry Ford Exercise Testing Project,(24) 64,561 
adults (46% female) were followed for a mean of 5-years. In this sample of patients 
who underwent physician-referred exercise testing, incident AF was ascertained 
using medical claims. High CRF was associated with a 56% reduction in AF risk, after 
adjustment for multiple risk factors. For every 1-MET achieved during treadmill 
testing, the risk of AF was reduced by 7%.  
The benefits of CRF on AF risk reduction were recently confirmed in an 
analysis of 5962 veterans followed for a median of 8 years,(25) in which AF incidence 
was determined by review of medical records. High CRF was associated with a 63% 
reduction in AF during follow-up. Furthermore, for each additional 1-MET achieved, 
the risk of AF declined by 21%.  
Despite CRF showing a strong, inverse relationship with subsequent AF risk 
(Figure-2), interpretation of this data should consider the elevated cardiovascular 
risk in most of the cohorts studied as well as variation in the ascertainment of AF and 
absence of any time-varying measures in the prediction models. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Exercise-Based Rehabilitation for Patients with AF 
Although exercise, physical activity and CRF provide benefit from the perspective of 
primary prevention, there has been an absence of studies assessing the benefit of 
exercise specifically for patients with AF. However, the favorable effects of lifestyle 
interventions including weight loss and risk factor management, including 
recommendations for exercise have shown significant clinical benefit.(26-29)  
The earliest data regarding exercise training was derived from patients with 
permanent AF. In two separate randomized studies, exercise training improved 
quality of life and exercise capacity amongst patients with permanent AF. 
(30)Collectively, although these studies indicate that patients with permanent AF 
gain significant health and functional benefits from exercise training, they do not 
address the role of exercise in the management of patients with non-permanent AF.  
In over 300 overweight or obese patients with paroxysmal or persistent AF, 
the CARDIOFIT study(31) assessed the role of CRF, measured at baseline, and its 
subsequent change over a 4-year follow-up. There were two notable findings from 
this study. First, those with the highest baseline CRF greater (>100% age and gender 
predicted values) were almost three times more likely to maintain arrhythmia 
freedom at final follow-up, without catheter ablation or anti-arrhythmic medication. 
Second, patients who gained CRF (>2-MET gain) throughout the follow-up were over 
two times more likely to maintain sinus rhythm. Importantly, the benefits of CRF in 
this study were achieved independently of weight change throughout follow-up, 
which has been demonstrated to promote arrhythmia freedom.(27, 28) 
The role of exercise training in patients with non-permanent AF was recently 
confirmed in a single center, randomised controlled trial of 12-weeks aerobic 
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interval training versus usual medical care.(32) In this cohort, AF burden declined by 
approximately 50% in the exercise group, and increased in the control group. 
Furthermore, AF symptoms and quality of life improved significantly for the exercise 
group. 
Alternative forms of activity such as yoga have been shown to reduce 
symptomatic and asymptomatic AF episodes when performed twice weekly for three 
months.(33) This finding warrants further investigation both as a stand-alone 
intervention and perhaps in a multidisciplinary approach including more traditional 
forms of exercise. 
To date, only one study has attempted to compare two types of exercise 
intervention in patients with AF.(34) Amongst 76 patients with paroxysmal or 
persistent AF, randomization to either low or high-intensity, group-based exercise 
training over 12 weeks did not result in any between-group differences in peak 
oxygen uptake or AF burden, recorded by daily ECG. Although this study did not 
specifically report the change in AF burden from baseline to follow-up, it does 
suggest that exercising at higher intensities may not provide additional gain.  
Although the evidence so far is limited, there appears to be a significant 
clinical benefit from the prescription of exercise to patients with AF.(35) Exercise 
lowers AF burden alongside and improves AF-specific symptoms and health-related 
quality of life. The key questions that remain unanswered are: (i) whether these 
findings can be translated into larger randomised studies with extended follow-up; 
and (ii) what are the mechanisms that promote the benefit of exercise in AF patients. 
 
How Does Physical Activity Reduce the Incidence of AF? 
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Although few studies have explored the mechanisms underlying the favorable 
benefits of exercise on AF, the current data offers several insights (Figure-3). The 
CARDIO-FIT study(31) showed that patients with significant gains in CRF also 
demonstrated lower blood pressure, inflammation and improved glycemic control, 
suggestive of a global improvement in risk factors. Furthermore, there were notable 
improvements both in LV size and diastolic function, and a significant reduction in LA 
size. When achieved in tandem, the benefits for patients with AF were considerable. 
However, alongside increases in weekly exercise, patients in CARDIO-FIT were also 
encouraged to lose weight, which may accentuate this benefit. In the later 
randomised controlled trial by Malmo et.al,(32) there was modest weight loss 
(~1.6Kg), with a subtle reduction in blood lipids. Interestingly, blood pressure 
remained the same and there was no change in LA size, although improvements in 
LA and LV function were observed. This study therefore suggests that the benefit of 
exercise on AF burden is not mediated solely through large shifts in weight or 
modifiable risk factors.  
The possibility that electrophysiological or autonomic changes promote the 
benefits of exercise in AF cannot be excluded. Exercise training improves autonomic 
tone principally by increasing vagal activity and reducing sympathetic 
activation.(36,37) Simultaneous sympathovagal discharges have been reported to 
precede the initiation of atrial arrhythmias.(38) Therefore, interventions that lower 
sympathetic activity may also reduce AF burden. Indeed, in heart failure patients, 
exercise training reduces sympathetic activation.(39)  
In addition to these potential mechanisms, there is a positive benefit of 
exercise on other AF-specific risk factors, including pericardial fat,(40) and 
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obstructive sleep apnea.(41) It is likely that a reduction of AF risk factors and 
favorable changes in mechanistic promoters of AF converge to provide an anti-
arrhythmic effect of regular exercise.  
 
Too much of a good thing? Endurance exercise and AF 
At the upper end of endurance training, there is a paradoxical increase in AF risk. 
Early case-control studies demonstrated an over-representation of athletes amongst 
patients with so-called ‘lone’ AF.(42,43) Similarly, studies of athletes versus non-
athletes support an excess of AF amongst endurance athletes.(44-47) In an early 
meta-analysis of six studies, athletes had a five-fold increase in the risk of AF 
compared to age matched controls (OR 5.3, 95% CI: 3.6-7.9).(48) More recently, in a 
comparison of participants from an annual cross-country ski race (mean age 69-
years) versus a cohort from a population-based health survey (mean age 72-years), 
the prevalence of AF was 13% amongst athletes versus 9.8% amongst non-athletes 
(OR 1.81, 95% CI: 1.04-3.14).(49) Some caution should be taken when interpreting 
many of these studies. First, AF is commonly ascertained by self-report, resulting in 
reporting bias. Second, recruitment bias may be evident in those studies where 
athletes and control participants were not recruited simultaneously.  
More compellingly, cohort studies with extended follow-up lend weight to 
the hypothesis that endurance exercise promotes AF. In over 16,000 males followed 
for 12-years in the Physicians’ Health Study, Aizer et.al, identified a 50% increase in 
the risk of AF for those who engaged in jogging 5-7 times/week.(50) Similarly, 
Andersen et.al,(51) reported arrhythmia incidence amongst over 52,000 former 
participants of a long-distance cross-country ski race. The authors reported the 
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arrhythmia incidence by: a) number of race completions, as a surrogate of training 
history; and b) proximity to the winners finishing time, as a surrogate of 
performance. AF occurred more frequently in participants with ≥5 race finishes, 
compared to those with only 1 race finish (OR 1.29, 95% CI: 1.04-1.61). However, 
there was no significant elevation of AF risk as a result of faster finishing time.  
There are several important points to consider in the interpretation of this 
evidence. First, risk estimates vary widely between studies, impairing the precise 
estimation of risk associated with endurance exercise. There is also evidence that 
high-intensity exercise training may be protective in females, yet proarrhythmogenic 
in males.(52) Second, there is a lack of objectivity in the reporting of training history, 
leading to inconsistencies between studies. Third, the ascertainment of AF continues 
to be an ongoing weakness. Finally, there remains a possibility that the symptoms of 
AF episodes may be more noticeable to an athlete, either at rest or during exercise, 
thus creating the potential for reporting bias. Future studies that provide the 
longitudinal assessment of athletes, including their exercise exposure, coupled with 
objective identification of AF diagnoses, will be critical in understanding the risk of 
AF associated with exercise. 
 
Mechanisms for AF promotion with endurance sports 
Recently, Wilhelm et.al,(53) proposed three potential mediators of atrial 
arrhythmogenesis in athletes; ectopic triggers, modulators and an altered atrial 
substrate. Studies in both humans and animals have shed some light on these and 
other potential pathways (Figure-4). 
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Seminal work by Haissaguerre et.al,(54) revealed that ectopic beats 
originating from the pulmonary veins frequently leads to the initiation of AF. 
Amongst former professional cyclists, atrial ectopy was no different to that of age-
matched golfers.(47) However, in runners, more extensive training history was 
associated with an increase in atrial ectopic burden,(46) albeit lower than that 
typically seen in AF patients.(55)  
Shifts in autonomic balance as a result of training have been shown in 
humans and animal models.(56,57) Increased autonomic activation can initiate 
pulmonary vein activity as well as leading to macro-reentry pathways by shortening 
the atrial refractory period.(58) Furthermore, abrupt shifts between vagal 
dominance and sympathetic drive, may facilitate the onset of AF.(59) In a rat model, 
Guasch et.al,(57) demonstrated enhanced vagal activity following 16 weeks of 
training. This alteration was temporally associated with an increase in AF inducibility. 
Interestingly, the reversal of vagal enhancement and AF inducibility was evident 
following detraining, supporting a contribution of autonomic shifts in the promotion 
of atrial arrhythmogenesis. However, in a mouse model of endurance training, 
inhibition of vagal tone did not eliminate AF susceptibility following training,(60) 
therefore suggesting that additional factors may be critical in the development of AF 
in endurance athletes. 
Atrial fibrillation occurs in the presence of an abnormal atrial substrate.(61) 
In athletes, the development of bi-atrial dilatation is well established and may 
contribute to the promotion of AF with exercise training.(62) Fibrosis is a common 
feature of the atrial substrate in both obesity(63) and hypertension.(64) In preclinical 
models, the development of fibrosis in the atria and ventricles of endurance-trained 
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rats is associated with an increase in the susceptibility to AF and ventricular 
arrhythmias.(57,65) Interestingly, atrial fibrosis did not fully resolved with 
detraining(57) despite a reversal of AF susceptibility. 
The mechanisms leading to the abnormal atrial substrate in athletes are likely 
multifactorial, including repeated stretch and activation of pro-fibrotic pathways 
alongside inflammation in the atria. The latter was confirmed in a mouse model 
whereby pharmacological inhibition of the pro-inflammatory cytokine TNF-α 
prevented the induction of fibrosis in the atrial wall following training, subsequently 
lowering the inducibility of AF.(60)  
Other potential mechanisms contributing to the excess of AF in athletes may 
be related to body stature. Recent evidence has highlighted the role of height and 
lean body mass(66) as a positive predictor of incident AF. In recent case-control data, 
both height and endurance exercise were significantly associated with AF in 
multivariate analyses.(62) Detailed anthropometric data from longitudinal studies in 
athletes will provide valuable insight into whether body stature and lean body mass 
contribute to AF risk amongst athletes. 
 
Where to from here? 
There is expanding evidence regarding physical activity, endurance exercise and their 
relationship with incident AF. The remaining knowledge gaps will need to be 
addressed with studies leveraging both scientific and technological advances. First, 
large epidemiological studies, in which physical activity may be quantified with the 
assistance of wearable devices, will be pivotal in eliminating the bias of self-reported 
exercise. In such studies, specific attention should be paid to the ascertainment of AF 
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beyond just medical records. Second, a longitudinal, prospective study of endurance 
athletes versus age-matched controls coupled with detailed phenotyping is required 
to advance our understanding of: (i) how endurance exercise modulates the risk of 
AF; and (ii) the mechanisms promoting AF in this cohort. Such studies should not 
only take advantage of new approaches to quantify exercise habits, but also 
advances in cardiac imaging to assess changes in the atrial substrate with training. 
Furthermore, assuming that endurance exercise does contribute to the promotion of 
AF, randomized studies comparing treatment strategies may be warranted. 
Summary 
From current evidence, moderate physical activity at the recommended guidelines 
may be insufficient to reduce incident AF. However, at a weekly physical activity 
dose >1000-MET-minutes, or approximately 3.5-hours of moderate walking/week, 
there appears to be a reduction in the risk of AF by approximately 10% (Figure-5).  
In addition, greater CRF appears to reduce the risk of AF development to a 
greater degree than physical activity alone. A CRF of >8-METs (or a peak VO2 >28 
ml/kg/min) is associated with a lower incidence of AF. Routine exercise testing may 
therefore offer the opportunity to identify patients with higher AF risk. 
The arrhythmogenic effects of endurance exercise are becoming well 
established, although the specific dose, above which AF risk is elevated, remains 
uncertain. Although some studies have advocated for a 2000-lifetime-hour 
threshold,(62) this likely lacks specificity in identifying at-risk individuals. Instead, 
cardiologists and sports physicians should choose to remain vigilant for arrhythmias 
in those individuals engaging in high volumes of endurance exercise. Strategies for 
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the management of AF in athletes is beyond the scope of this review but has been 
discussed elsewhere.(35) 
Finally, for the patient with existing non-permanent AF, exercise training 
appears to confer an anti-arrhythmic benefit in both short and long-term follow-up. 
Although there is limited data to develop specific guidelines, an exercise volume of 
210-minutes/week with the inclusion of vigorous exercise would be an effective 
guideline. However, further studies justifying the benefits of exercise for patients 
with AF are urgently needed.  
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FIGURE LEGEND 
Figure-1. Upper: Risk associated with levels of weekly physical activity for individual 
studies in which the exercise dose can be computed. Lower: Estimated best-fit 
model assessing the AF risk change (95% CI in shaded area) with increasing doses of 
physical activity (MET-mins), plotted using local polynomial regression. 
Figure-2. Bubble plot depicting data from three studies assessing the relationship 
between CRF and AF incidence. Symbol colors indicate the study, whilst symbol size 
is proportional to group sample size. AF incidence rates were calculated from 
reported study data. A lower incidence of AF can be seen in study groups with a CRF 
>8-METs. 
Figure-3. Potential mechanisms contributing to the beneficial effects of exercise in 
patients with non-permanent AF. 
Figure-4. Summary of potential mechanisms promoting atrial arrhythmogenesis in 
endurance-trained athletes. 
Figure-5. Recommendations for physical activity and exercise in the prevention and 
treatment of AF. Current evidence suggests a lower risk of AF in those who 
participate in >220-minutes of moderate activity, or who demonstrate a CRF >8-
METs. For patients with existing non-permanent AF, exercise up to 210-
minutes/week and aerobic interval training have been shown to lower the burden of 
AF, and reduce long-term recurrences of AF, alongside appropriate risk factor 
management. Adapted from Elliott et.al,(35) and Lau et.al.(29) 
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